Sobi is presenting a total of 15 scientific abstracts, with six oral presentations featuring new clinical data from completed and ongoing studies of NASP, pacritinib, and emapalumab-lzsg. "The data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback